Furthermore, the present study, using a comparative large-scale transcriptome analysis of TAMR and ADR cells, identified ITGA11 as a master regulator that drives CSC expansion and drug resistance in breast cancer cells, independent of the type of anti-breast cancer drug. The gene discussed is ITGA11; the disease is breast carcinoma.